Facebook
Twitter
LinkedIn
Forward14th Annual Inflammatory Bowel Disease: The Art and Science in the Diagnosis and Treatment 2021
Join us in-person or online for IBD Boston 2021.
Please note that we have a limited number of in-person spaces that will be filled on a first come, first served basis.
In person attendees must attest that they have been fully vaccinated (14 days snice last dose) before attending the meeting. If you will not be fully vaccinated or feel ill on the day, we respectfully ask that you attend the meeting virtually.
At this time (9/13), all speakers with the exception of Drs. Burakoff and Dubinsky and Ms. Omprakash will be presenting in person.
Please note we will be following all Boston University, City of Boston and Marriott event and meeting protocols. Masks must be worn at all times regardless of vaccination status except when drinking and eating. Please stay home if you feel unwell or have any COVID-19 symptoms. We can convert your registration attend virtually if you are not vaccinated or if you feel sick. We will provide masks and hand sanitizer. Registration and meals will be as contactless as possible. Please see the below links for more information:
Boston University Events and Meeting Policies: https://www.bu.edu/back2bu/work-life-faculty-staff/catering-events-meetings/
Marriott Policies: https://clean.marriott.com/
City of Boston: https://www.boston.gov/news/what-you-need-know-about-mask-requirements
We are pleased to announce that the Boston IBD 2021 meeting will be a hybrid meeting in 2021. We will hold an in-person meeting at the Aloft Hotel in Boston (following all Federal, State and local guidelines to do so safely) while broadcasting the meeting simultaneously on a virtual platform. Attendees have a choice to attend in person or virtually.
The goal of this hybrid conference is to initiate practice changes in gastroenterology practices in the diagnosis and management of patients with CD and UC so as to improve quality of life for these patients while prolonging clinical remission. This conference will provide support and enable participating clinicians to enhance their knowledge, competency, and performance in the areas of patient care, medical knowledge, and practice-based learning and improvement
What past attendees have said about the Boston IBD Meeting:
"Excellent conference! Case discussions were good."
"Wonderful and as always highly educational! Provides useful information we can apply to our practice daily."
Acknowledgement
Education program is provided by:
- Boston University School of Medicine | Continuing Medical Education
In conjunction with:
- Boston Medical Center
- Beth Israel Deaconess Medical Center
- Brigham and Women’s Hospital
- Boston Children’s Hospital
- Lahey Hospital & Medical Center
- Massachusetts General Hospital
- Tufts Medical Center
- UMass Memorial Medical Center
Supported by educational grants from:
- Takeda Pharmaceuticals U.S.A., Inc.
- Pfizer, Inc.
- Bristol Myers Squibb
- Supported, in part, by an educational grant from Ferring Pharmaceuticals, Inc
- Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Supported by exhbits from:
- Abbvie
- Arena Pharmaceuticals
- Bristol Myers Squibb
- Eli Lilly
- Gilead
- Janssen
- Organon
- Pfizer
- Takeda Pharmaceuticals U.S.A., Inc.
Endorsed by the Crohn’s & Colitis Foundation
Our friends at the Crohn’s & Colitis Foundation are hosting their annual fundraising event Royal Flush for Crohn’s & Colitis on Friday, September 24th at 7:00pm at THE LAWN ON D (420 D St, Boston MA) which is across the street from the IBD Boston venue. All healthcare workers receive special recognition at the event and $17.50 off the ticketed price by using the code HCP10. This cocktail style event includes hors devours, dinner, open bar, casino games galore and a beautiful night celebrating the IBD community. Purchase your ticket here.
Target Audience
This course is designed for practicing gastroenterologists, pediatric gastroenterologists, colorectal surgeons, NP/PAs, nurses and other health care professionals caring for patients with CD and UC.
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Discuss emerging agents for IBD in terms of therapeutic target, safety and efficacy data, and place in therapy.
- Critically assess targets of mucosal healing used in treat-to-target strategies and the evidence that exists to support the use of these strategies in IBD patients.
- Differentiate the benefits and risks of biologic treatments in patients with IBD.
- Recognize the value and role of therapeutic drug monitoring.
- Explore the complex interplay of IBD and fertility concerns, pregnancy, and sexual function in women’s health.
- Evaluate key considerations and the latest emerging data for managing IBD in the era of COVID-19.
- Interpret expert insights and emerging data for the novel treatment of C.diff recurrence with fecal microbiota transplantation.
- Promote and advocate for the patient’s role and voice in IBD shared decision-making to drive a more patient-oriented treatment approach.
- Evaluate the role of nutrition in the control of IBD and understand how diet affects microbiota.
- Review the role of diagnostic imaging and endoscopic biopsy in the diagnosis and monitoring of CD and UC.
- Identify the most current approaches to the management of postoperative recurrence in CD.
- Describe the medical and surgical approaches in patients with severe UC and pouchitis.
- Recognize the benefits of health maintenance (immunizations, psychosocial screening, and skeletal health assessment) in patients with CD and UC.
- Recognize how to effectively advocate for your patient when third party payors or specialty pharmacies deny care or access to needed treatments.
- Evaluate and treat extraintestinal manifestations in IBD
- Articulate the importance of the interprofessional team in providing care for patients with IBD
Additional Information
| Attachment | Size |
|---|---|
 Printable Agenda | 180.04 KB |
Friday - September 24, 2021 | |
Time (ET) | Agenda Description |
12:00 PM | Registration (In-Person and Online) |
1:00 PM | Welcome and Introduction |
1:15 PM | Keynote: FMT and C diff and IBD Jessica Allegretti, MD |
2:00 PM | New Drugs on the Horizon Samir Shah, MD, FACG, FASGE, AGAF |
2:25 PM | What is the Role of Nutrition Controlling IBD? Sophie Burge, MS, RDN, LD |
2:50 PM | Panel: Case Based Talks on Biologics Moderator: Adam Cheifetz, MD; Panel: Randall Pellish, MD, Matthew J. Hamilton, MD, Robert Burakoff, MD |
3:35 pm | Break |
3:55 pm | IBD: The Pandemic Year in Review Athos Bousvaros, MD |
4:20 pm | Panel: Medical And Surgical Treatment Of IBD Moderator: Joseph D. Feuerstein, MD; Panel: Joel Goldberg, MD, Rachel Winter, MD, Alan Moss, MD |
5:05 pm | Checkpoint Inhibitor Colitis -Shilpa Grover MD, MPH |
5:30 pm | Adjourn |
Saturday – September 25, 2021 | |
Time (ET) | Agenda Description |
7:30 AM | Registration and Breakfast (In Person Attendees) |
8:00 AM | Introduction |
8:05 AM | Keynote: Treat to Target: Practical Applications in Clinical Practice Gary R. Lichtenstein, MD |
8:50 AM | Hot Topics in Surgery Moderator: Jason Hall. MD ; Panelists: Belinda Dickie, MD, PhD, Angela Kuhnen, MD, FACS, FASCRS |
9:40 AM | Panel: Pouch And Pouch Complications Moderator: Laurie Grossberg, MD; Panel: Jason Hall, MD, Joel Weinstock, MD |
10:25 AM | Break |
10:45 AM | Dermatology and IBD Debjani Sahni, MD |
11:10 AM | IBD and Rheumatology Gwendolyn Freda Kane-Wanger, MD |
11:35 AM | Hot Topics in Pediatric IBD Christopher Moran, MD |
12:00 PM | The IBD Patient Voice Tina Aswani Omprakash |
12:25 PM | Break (Lunch – In-Person) |
1:20 PM | Keynote: Positioning Marla Dubinsky, MD |
2:05 PM | Panel: Sexual Function, Pregnancy and Fertility Cases Moderator: Sonia Friedman, MD; Panelists: Thomas Frederick McElrath, MD, PHD, Meghan Markowski Cucchiara, PT, Christy Cauley , MD MPH |
2:50 PM | How To Determine Remission In IBD: Biomarkers, MRE/CTE/US, Endoscopy, Histology and What Should We Aim For? Alan C. Moss, MD |
3:15 PM | Break |
3:30PM | Panel: Infections in IBD, including COVID-19 Moderator: Sharmeel Wasan, MD; Panelists: Samir Shah, MD, FACG, FASGE, AGAF, Stacy Kahn, MD |
4:15 PM | Severe Acute Colitis Ashwin Ananthakrishnan, MD |
4:40 PM | Adjourn |
Our friends at the Crohn’s & Colitis Foundation are hosting their annual fundraising event on Friday, September 24th at 7:00pm at THE LAWN ON D (420 D St, Boston MA) which is across the street from the IBD Boston venue. Event details are here: https://one.bidpal.net/royalflush2021/welcome
In-Person
A block of rooms has been reserved at the Aloft Boston Seaport Hotel with an arrival date of 9/24/21 and a departure date of 9/27/21. The room rate is $329, single or double, plus applicable taxes. To receive this rate you may:
- Call the central reservations team at 877-462-5638 to make your reservations Reference the group name, Boston IBD
- Book online here: https://www.marriott.com/event-reservations/reservation-link.mi?id=1617285263028&key=GRP&app=resvlink
The room block will be open until 5:00pm local time on 9/2/21 or until it sells out, whichever happens first.
*By staying at the conference venue, you help the host organizations meet their contractual obligations. Please take this into consideration when making your accommodation decision.
Online (Virtual Live Stream)
Online attendees will receive connection information a week prior to the meeting. Lectures will be streamed in real time. Attendees will be able to downloard, materials, ask questions as well as visit with our exhibitors.
Jessica R. Allegretti, MD, MPH, FACG
Director of Clinical Research
Director, Fecal Microbiota Transplant Program
Associate Director, Crohn's and Colitis Center
Division of Gastroenterology, Hepatology and Endoscopy
Brigham and Women's Hospital
Assistant Professor of Medicine, Harvard Medical School
Ashwin Ananthakrishnan, MD, MPH
Associate Professor of Medicine
Harvard Medical School
Director, Crohn’s and Colitis Center
Massachusetts General Hospital
Tina Aswani Omprakash
Founder, Own Your Crohn's & Co-Founder, IBDesis
MPH Candidate '23, Mount Sinai Icahn School of Medicine
Diversity Chairperson, Girls With Guts
Athos Bousvaros, MD, MPH
Course Co-Director
Associate Professor of Pediatrics, Harvard Medical School
Associate Director
IBD Center Associate Chief, Division of Gastroenterology
Boston Children’s Hospital
Robert Burakoff, MD, MPH, FACG, AGAF
Professor of Medicine
Weill Cornell Medical College
Vice Chair of Medicine,
Ambulatory Services
Department of Medicine
Weill Cornell Medical College
Professor Emeritus, Harvard Medical School
Sophie Burge, MS, RDN, LD
Clinical Nutrition Specialist II, Optimal Wellness for Life (OWL)
Boston Children's Hospital
Christy Cauley , MD, MPH
Assistant Professor
MGH: Colon & Rectal Surgery
Ariadne Labs
Adam Cheifetz, MD
Director of the Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Professor of Medicine at Harvard Medical School
Belinda Dickie, MD, PhD
Director, Colorectal and Pelvic Malformation Center; Assistant in Surgery, Department of Surgery
Assistant Professor, Harvard Medical School
Boston Children's Hospital
Marla Dubinsky, MD
Professor of Medicine and Pediatrics
Chief of Pediatric Gastroenterology and Nutrition
Mount Sinai Kravis Children’s Hospital
Co-Director, Susan and Leonard Feinstein IBD Clinical Center
Icahn School of Medicine, Mount Sinai
Joseph D. Feuerstein, MD
Associate Clinical Chief, Gastroenterology
Center for Inflammatory Bowel Disease
Associate Professor of Medicine, Harvard Medical School
Beth Israel Deaconess Medical Center
Sonia Friedman, MD, FACG
Course Co-Director
Associate Professor of Medicine
Harvard Medical School
Associate Physician
Brigham and Women’s Hospital
Joel Goldberg, MD, MPH, FACS
Assistant Professor of Surgery
Harvard Medical School
Colon and Rectal Surgery
Brigham and Women's Hospital
Laurie Grossberg, MD
Center for Inflammatory Bowel Disease
Beth Israel Deaconess Medical Center
Shilpa Grover, MD, MPH, AGAF
Director, Onco-Gastroenterology Program
Division of Gastroenterology
Brigham and Women’s Hospital
Jason Hall, MD, MPH
Chief, Colon & Rectal Surgery
Co-Director, Dempsey Center for Digestive Disorders
Associate Professor of Surgery, Boston Medical Center
Matthew Hamilton, MD
Division of Gastroenterology
Director of Translational Research
Crohn's and Colitis Center
Brigham and Women’s Hospital
Assistant Professor of Medicine
Harvard Medical School
Stacy A. Kahn, MD
Director, Fecal Microbiota Transplantation; Attending Physician, Division of Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics, Harvard Medical School
Boston Children’s Hospital
Gwendolyn Freda Kane-Wanger, MD
Rheumatology
Brigham and Women's Hospital
Joshua Korzenik, MD
Assistant Professor of Medicine
Harvard Medical School
Director, BWH Crohn’s and Colitis Center
Brigham and Women’s Hospital
Angela Kuhnen, MD, FACS, FASCRS
Surgical Director, Inflammatory Bowel Disease Center
Associate Program Director, Colon and Rectal Surgery Residency
Assistant Professor of Surgery Lahey Hospital & Medical Center
Gary R. Lichtenstein, MD
Professor of Medicine
Raymond and Ruth Perelman School of Medicine of the Univeristy of Pennsylvania
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
Meghan Markowski Cucchiara, PT, DPT, WCS, BCB-PMD
Clinical Specialist Physical Therapist, Lead Pelvic Health Therapist
Board Certified Clinical Specialist in Women’s Health Physical Therapy
Board Certified in Pelvic Muscle Dysfunction Biofeedback
Brigham and Women’s Hospital
Thomas McElrath, MD, PhD
Associate Professor, Harvard Medical School
Division of Maternal-Fetal Medicine, Brigham and Women’s Hospital
Christopher Moran, MD
Assistant Professor of Pediatrics
Harvard Medical School
Associate Pediatrician
MassGeneral Hospital for Children
Alan Moss, MD, FACG, FEBG, AGAF, FRCPI
Professor of Medicine at Boston University School of Medicine
Director of the Crohn’s & Colitis Program
Boston Medical Center
Randall Pellish, MD
Director, Inflammatory Bowel Disease Center
Division of Gastroenterology
Lahey Hospital & Medical Center
Paul A. Rufo, MD, MMSc
Program Director, Harvard Medical School Fellowship in Pediatric Gastroenterology
Division of Gastroenterology
Boston Children's Hospital
Assistant Professor of Pediatrics
Harvard Medical School
Debjani Sahni, MBBS
Assistant Professor of Dermatology
Boston University School of Medicine
Dermatologist
Boston Medical Center
Samir Shah, MD, FACG, FASGE, AGAF
Clinical Professor of Medicine
Alpert Medical School of Brown University
Chief of Gastroenterology, The Miriam Hospital
Gastroenterology Associates, Inc.
Sharmeel Wasan, MD, FACG
Course Co-Director
Associate Professor of Medicine, Boston University School of Medicine
Fellowship Program Director, Section of Gastroenterology
Boston Medical Center
Joel Weinstock, MD
Professor at Tufts University and Tufts Medical Center
Director of Crohn’s and Colitis Center at Tufts Medical Center
Rachel Winter, MD, MPH
Instructor in Medicine, Harvard Medical School
Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women’s Hospital
CME Program Manager: Claire P. Grimble, CMP
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Boston University School of Medicine designates this live activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participantswill earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 11 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.*
By attending this activity and providing your ABIM or ABP number and Date of Birth, you authorize BUSM CME office to report your information to the ACCME so that we may process your MOC Part II credit on your behalf.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 11.25 of which 8.0 is eligible for pharmacology credit.
Application will be made to the American Board of Certification for Gastroenterology Nurses (ABCGN)
Available Credit
- 11.25 ABCGNAccording to the criteria of the American Board of Certification for Gastroenterology Nurses (ABCGN), the approved hours in this activity are considered GI Specific for the purpose of recertification by contact hours through the ABCGN. Specific Category Approved: ABCGN21_076 Hours Approved: 11.25
- 11.00 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 11.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 11.25 ANCC
- 8.00 ANCC Pharmacology
- 11.00 Participation
Supported by educational grants from:
- Takeda Pharmaceuticals U.S.A., Inc.
- Pfizer, Inc.
- Bristol Myers Squibb
- supported, in part, by an educational grant from Ferring Pharmaceuticals, Inc
- Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Supported by exhbits from:
- Abbvie
- Arena Pharmaceuticals
- Bristol Myers Squibb
- Eli Lilly
- Gilead
- Janssen
- Organon
- Pfizer
- Takeda Pharmaceuticals U.S.A., Inc.
Price
| MD/DO | $199 |
| Allied Healthcare (RN, PA, NP) | $149 |
| Fellows/Resident/Student | $100 |
| BUSM Alumni | $160 |
Please note the per person costs are the same for both in-person or virtual attendance.
To pay by check, please create an account and email us at cme@bu.edu or call 617-358-5005 and we will assist you.
Cancellation Policy
Substitutions may be made at any time without an additional charge. Refunds, less an $50 administrative fee, will be issued for all cancellations received two weeks prior to the start of the meeting. Should cancellation occur within the two-week window, a credit will be issued, not a refund. Credits will be honored for up to two years. “No shows” are subject to the full course fee. Cancellations/substitution(s) must be made in writing. Refunds or credits will not be issued once the conference has started. This course is subject to change or cancellation.
If you need to cancel your registration, please click here.
Special Services / Dietary Needs
To request reasonable accommodations for disabilities, please notify the Office of Continuing Medical Education in writing at least two weeks prior to the start of the conference. The Office of Continuing Medical Education will work to accommodate dietary requests (including, but not limited to: kosher, vegetarian, low cholesterol, and low sodium) received in writing at least two weeks prior to the start of the conference
Please Note
The conference organizers may take pictures or record videos during the conference. In registering for the conference, you acknowledge that BUSM may photograph you during the meeting, and you agree that we may include images of yourself, intact or in part, for conference promotional activities or other related endeavors. This material may also appear on the conference's website or associated social media outlets. If you do not wish to be photographed, please let the BUSM representative onsite know
If you have any questions, special requests, or need to cancel your registration for this activity, please contact BU CME/CNE at (617) 358-5005 or cme@bu.edu. For any concerns that cannot be resolved with BU CME/CNE directly, please follow the complaint resolution process outlined on the State Authorization & Distance Education Website: http://www.bu.edu/state-authorization/.